Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.735 EUR | +9.81% | +6.45% | +27.91% |
Evolution of the average Target Price on aTyr Pharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering aTyr Pharma, Inc.
RBC Capital Markets | |
Piper Sandler | |
Oppenheimer | |
Roth MKM | |
HC Wainwright | |
Roth Capital Partners | |
JonesTrading Institutional Services | |
Laidlaw & Co. |
EPS Revisions
- Stock Market
- Equities
- LIFE Stock
- 471A Stock
- Consensus aTyr Pharma, Inc.